mPathix Health Inc. acquired Qualis Innovations, Inc. (OTCPK:QLIS) in a reverse merger transaction on June 28, 2021. As a result of the share exchange, Qualis will install its new board of directors: Demir Bingol, Chairman and Chief Executive Officer, John Ballard, Chief Financial Officer and Board Member, Joseph Pergolizzi, Managing Director, Board Member, Jim Holt and Madding King, Board Members. mPathix Health Inc. completed the acquisition of Qualis Innovations, Inc. (OTCPK:QLIS) in a reverse merger transaction on June 29, 2021. In exchange, Qualis issued to mPathix?s shareholders, their designees or assigns, an aggregate of 6,988,300 shares of Qualis common stock, or approximately 93.4% of the shares of common stock of Qualis issued and outstanding immediately after closing, and Qualis issued warrants to purchase an additional 1,098,830 shares of Qualis common stock, exercisable for 10 years at a $0.50 per share exercise price, subject to adjustment. In connection with the closing of acquisition, the officers and directors of mPathix were appointed as the officers and directors of Qualis.